Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Efficacy and tolerability of initial antiretroviral therapy: a systematic review.

Carr A, Amin J.

AIDS. 2009 Jan 28;23(3):343-53; discussion 355-6. doi: 10.1097/QAD.0b013e32831db232. Review.

PMID:
19114855
2.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
3.

Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.

Landman R, Capitant C, Descamps D, Chazallon C, Peytavin G, Katlama C, Pialoux G, Bentata M, Brun-Vézinet F, Aboulker JP, Yéni P; ANRS 127 Study Group.

J Antimicrob Chemother. 2009 Jul;64(1):118-25. doi: 10.1093/jac/dkp146. Epub 2009 May 6.

PMID:
19420019
4.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update January 2007)].

Panel de expertos de GESIDA; Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2007 Jan;25(1):32-53. Spanish.

PMID:
17261244
5.

CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.

Torti C, Lapadula G, Barreiro P, Soriano V, Mandalia S, De Silvestri A, Suter F, Maggiolo F, Antinori A, Antonucci F, Maserati R, El Hamad I, Pierotti P, Sighinolfi L, Migliorino G, Ladisa N, Carosi G; Italian MASTER Cohort.

J Antimicrob Chemother. 2007 Jun;59(6):1141-7. Epub 2007 Apr 13.

PMID:
17434879
6.

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.

Antivir Ther. 2009;14(3):339-47.

PMID:
19474468
7.

Once-a-day highly active antiretroviral therapy: a systematic review.

Ena J, Pasquau F.

Clin Infect Dis. 2003 May 1;36(9):1186-90. Epub 2003 Apr 21.

PMID:
12715315
8.

Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women.

Cocohoba J, Wang QJ, Cox C, Gange SJ, Cohen M, Glesby M, DeHovitz JA, Greenblatt RM.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):377-83. doi: 10.1097/QAI.0b013e318160d552.

PMID:
18176324
9.

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.

Pujades-Rodríguez M, O'Brien D, Humblet P, Calmy A.

AIDS. 2008 Jul 11;22(11):1305-12. doi: 10.1097/QAD.0b013e3282fa75b9.

PMID:
18580610
10.

Efficacy of initial antiretroviral therapy for HIV-1 infection in adults: a systematic review and meta-analysis of 114 studies with up to 144 weeks' follow-up.

Lee FJ, Amin J, Carr A.

PLoS One. 2014 May 15;9(5):e97482. doi: 10.1371/journal.pone.0097482. eCollection 2014. Review.

11.

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.

Ivers LC, Kendrick D, Doucette K.

Clin Infect Dis. 2005 Jul 15;41(2):217-24. Epub 2005 May 27.

PMID:
15983918
12.

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.

Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):56-63. Erratum in: J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):529.

PMID:
19731418
13.

National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?

Beck EJ, Vitoria M, Mandalia S, Crowley S, Gilks CF, Souteyrand Y.

AIDS. 2006 Jul 13;20(11):1497-502.

PMID:
16847404
14.

Antiretroviral therapy in treatment-naïve patients with HIV infection.

Camacho R, Teófilo E.

Curr Opin HIV AIDS. 2011 Dec;6 Suppl 1:S3-11. doi: 10.1097/01.COH.0000410239.88517.00. Review.

PMID:
22156777
15.

Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial.

Sarna A, Luchters S, Geibel S, Chersich MF, Munyao P, Kaai S, Mandaliya KN, Shikely KS, Temmerman M, Rutenberg N.

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):611-9. doi: 10.1097/QAI.0b013e3181806bf1.

PMID:
18645509
16.

Unmeasured confounding caused slightly better response to HAART within than outside a randomized controlled trial.

Hansen AB, Gerstoft J, Kirk O, Mathiesen L, Pedersen C, Nielsen H, Jensen-Fangel S, Sørensen HT, Obel N.

J Clin Epidemiol. 2008 Jan;61(1):87-94. Epub 2007 Aug 3.

PMID:
18083465
17.

Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy.

Heath KV, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS.

J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):211-7.

PMID:
12394800
18.

Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.

Sungkanuparph S, Anekthananon T, Hiransuthikul N, Bowonwatanuwong C, Supparatpinyo K, Mootsikapun P, Chetchotisakd P, Kiertiburanakul S, Tansuphaswadikul S, Buppanharun W, Manosuthi W, Techasathit W, Ratanasuwan W, Tantisiriwat W, Suwanagool S, Leechawengwongs M, Ruxrungtham K; Thai AIDS Society.

J Med Assoc Thai. 2008 Dec;91(12):1925-35.

PMID:
19133532
19.

Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.

Bonora S, Nicastri E, Calcagno A, Gonzalez de Requena D, D'Ettorre G, Sarmati L, Palmisano L, Vullo V, Di Perri G, Andreoni M.

J Med Virol. 2009 Mar;81(3):400-5. doi: 10.1002/jmv.21405.

PMID:
19152404
20.

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.

Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, Ngeth C, Ferradini L, Delfraissy JF, Laureillard D.

Antivir Ther. 2008;13(5):697-703.

Supplemental Content

Support Center